Protocol

Mouse Mutagenesis Using N-Ethyl-N-Nitrosourea (ENU)

  1. Monica J. Justice1
  1. Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA
  1. 1Corresponding author (mjustice{at}bcm.tmc.edu)

INTRODUCTION

This protocol describes chemical mutagenesis of male mice using N-ethyl-N-nitrosourea (ENU), which is the most efficient method for obtaining mouse mutations in phenotype-driven screens. A fractionated dose of ENU, an alkylating agent, can produce a mutation rate as high as 1.5 × 10−3 in male mouse spermatogonial stem cells. Treatment with ENU produces point mutations that provide a unique mutant resource: They reflect the consequences of single gene changes independent of position effects, provide a fine structure dissection of protein function, display a range of mutant effects from complete or partial loss of function to exaggerated function, and discover gene functions in an unbiased manner. After treatment with ENU, mice are mated in genetic screens designed to uncover mutations of interest. Screens for dominant, recessive, and modifying mutations can be performed.

| Table of Contents